These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9252849

  • 1. A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis.
    Floreani A, Zappala F, Fries W, Naccarato R, Plebani M, D'Angelo A, Chiaramonte M.
    J Clin Gastroenterol; 1997 Jun; 24(4):239-44. PubMed ID: 9252849
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment.
    Floreani A, Chiaramonte M, Giannini S, Malvasi L, Lodetti MG, Castrignano R, Giacomini A, D'Angelo A, Naccarato R.
    J Hepatol; 1991 Mar; 12(2):217-23. PubMed ID: 2051000
    [Abstract] [Full Text] [Related]

  • 3. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A, Crosignani A, Varenna M, Giussani CS, Allocca M, Zuin M, Podda M, Battezzati PM.
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [Abstract] [Full Text] [Related]

  • 4. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX, Li H.
    Chin Med J (Engl); 2008 Jul 20; 121(14):1280-4. PubMed ID: 18713548
    [Abstract] [Full Text] [Related]

  • 5. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.
    Clin Rheumatol; 2005 Jun 20; 24(3):232-8. PubMed ID: 15647969
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis.
    Ormarsdóttir S, Mallmin H, Naessén T, Petrén-Mallmin M, Broomé U, Hultcrantz R, Lööf L.
    J Intern Med; 2004 Jul 20; 256(1):63-9. PubMed ID: 15189367
    [Abstract] [Full Text] [Related]

  • 8. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
    Crippin JS, Jorgensen RA, Dickson ER, Lindor KD.
    Am J Gastroenterol; 1994 Jan 20; 89(1):47-50. PubMed ID: 8273797
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of calcitriol in treating glucocorticoidinduced osteoporosis in patients with nephrotic syndrome: an open-label, randomized controlled study.
    Chen Y, Wan JX, Jiang DW, Fu BB, Cui J, Li GF, Chen CM.
    Clin Nephrol; 2015 Nov 20; 84(5):262-9. PubMed ID: 26396095
    [Abstract] [Full Text] [Related]

  • 10. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
    Shane E, Rodino MA, McMahon DJ, Addesso V, Staron RB, Seibel MJ, Mancini D, Michler RE, Lo SH.
    J Heart Lung Transplant; 1998 Nov 20; 17(11):1089-96. PubMed ID: 9855448
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb 20; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 12. Sickle cell bone disease: response to vitamin D and calcium.
    Adewoye AH, Chen TC, Ma Q, McMahon L, Mathieu J, Malabanan A, Steinberg MH, Holick MF.
    Am J Hematol; 2008 Apr 20; 83(4):271-4. PubMed ID: 17924548
    [Abstract] [Full Text] [Related]

  • 13. Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.
    Soo I, Siffledeen J, Siminoski K, McQueen B, Fedorak RN.
    J Crohns Colitis; 2012 Aug 20; 6(7):777-86. PubMed ID: 22398088
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Primary biliary cirrhosis and osteoporosis: a case-control study.
    Mounach A, Ouzzif Z, Wariaghli G, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, El Maghraoui A.
    J Bone Miner Metab; 2008 Aug 20; 26(4):379-84. PubMed ID: 18600405
    [Abstract] [Full Text] [Related]

  • 18. Sodium fluoride prevents bone loss in primary biliary cirrhosis.
    Guañabens N, Parés A, del Rio L, Roca M, Gómez R, Muñoz J, Rodés J.
    J Hepatol; 1992 Jul 20; 15(3):345-9. PubMed ID: 1447501
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of osteoporosis in primary biliary cirrhosis.
    Wolfhagen FH, van Buuren HR, Vleggaar FP, Schalm SW.
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug 20; 14(4):629-41. PubMed ID: 10976019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.